Evidence map›Paper›PMID 38549660›Full record

ArticleJournal of education and health promotion2024

Effect of vaccine dose on

Andi Magfirah Hamsi, Ridwan Amiruddin, A Arsunan Arsin, Andi Zulkifli Abdullah, Hasnawati Amqam, Shanti Riskiyani

Open access · goldAbstract read
In one paragraph

Article in Journal of education and health promotion, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andi Magfirah HamsiDepartment of Epidemiology, Faculty of Public Health, Hasanuddin University, Indonesia.
Ridwan AmiruddinDepartment of Epidemiology, Faculty of Public Health, Hasanuddin University, Indonesia.
A Arsunan ArsinDepartment of Epidemiology, Faculty of Public Health, Hasanuddin University, Indonesia.
Andi Zulkifli AbdullahDepartment of Epidemiology, Faculty of Public Health, Hasanuddin University, Indonesia.
Hasnawati AmqamDepartment of Environmental Health, Faculty of Public Health, Hasanuddin University, Indonesia.
Shanti RiskiyaniDepartment of Health Promotion, Faculty of Public Health, Hasanuddin University, Indonesia.
Hasanuddin University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe administration of the coronavirus disease 2019 (COVID-19) vaccine aims to stimulate the production of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies. This leads to an enhanced production of neutralizing antibodies (Nabs), which naturally neutralize the virus within the body, thereby reducing the risk of COVID-19 infection. This study determined the analysis of factors affecting SARS-CoV-2 antibody levels in vaccinated individuals using data from the COVID-19 Seroepidemiological Survey of Gowa Regency. METHODS AND MATERIAL: This was an STATISTICAL ANALYSIS USED: Data analysis was conducted using various statistical tests, including the independent-samples

resultsThere was a significant influence between the history of COVID-19 infection (

conclusionsThe most influential factor was the vaccine dose on SARS-CoV-2 antibody levels in community in Gowa Regency.

Indexed as

ComorbiditiesCOVID-19 infectionSARS-CoV-2 antibody levelsvaccine dosevitamin consumption

Identifiers

PMID38549660
PMCPMC10977628
OpenAlexW4392154152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.